The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,796.00
Bid: 1,788.00
Ask: 1,796.00
Change: -50.00 (-2.71%)
Spread: 8.00 (0.447%)
Open: 1,882.00
High: 1,882.00
Low: 1,762.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Mar 2018 18:38

RNS Number : 7608G
Genus PLC
05 March 2018
 

5 March 2018

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces the following Director/PDMR Shareholding transactions:

· Jonathan Lightner, Chief Scientific Officer & Head of Genus R&D, sold 2,969 ordinary shares in the Company on 1 March 2018 on the London Stock Exchange at a price of 2,200 pence per share;

 

· Further to the vesting of contingent rights over ordinary shares in Genus on 28 February 2018 under an individual restricted stock award agreement (the 'RSA'), Dr. Nate Zwald, a member of the Genus Executive Leadership Team ('GELT'), sold ordinary shares in Genus on 2 March 2018, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares; and

 

· Further to the vesting of conditional nil-cost options on 20 November 2017 under the Genus Deferred Share Bonus Plan (the 'DSBP') and the Genus 2014 Performance Share Plan (the 'PSP'), Bill Christianson, a member of GELT, sold ordinary shares in Genus on 2 March 2018 and 5 March 2018 respectively, on the London Stock Exchange to offset income tax and social security liabilities due on the exercises, and retained the balance of ordinary shares.

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of nil-cost options and contingent rights exercised and ordinary shares sold.

 

 

For further information please contact:

 

Genus:

Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT Private Share Sale

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of 2,969 ordinary shares.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,200p

2,969

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

Average price(s)

 

Total volume(s)

2,200p

2,969

e.

Date of the transaction

2018-03-01

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Restricted Stock Award Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Dr. Nate Zwald

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus ABS Dairy

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 3,613 contingent rights under the RSA.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

3,613

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

3,613

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

b.

Nature of the transaction

Sale of 1,352 shares arising from the exercise of contingent rights under the RSA to offset income tax and social security liabilities due on the exercise.

c.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,208p

1,352

d.

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,208p

1,352

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

Table C - GELT Deferred Share Bonus Plan Exercise 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bill Christianson

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus PIC

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 1,515 nil-cost options under the DSBP.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

1,515

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

0p

1,515

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

e.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

f.

b.

Nature of the transaction

Sale of 608 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

g.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,208p

608

h.

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,208p

608

e.

Date of the transaction

2018-03-02

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

Table D - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bill Christianson

2.

Reason for the notification

a.

Position/status

Chief Operating Officer, Genus PIC

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 21,827 nil-cost options under the PSP.

 

 

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

21,827

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

Average price(s)

 

Total volume(s)

0p

21,827

e.

Date of the transaction

2018-03-05

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

GB0002074580

b.

Nature of the transaction

Sale of 8,758 shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,191.7014p

8,758

d.

Aggregated information

· Aggregated volume

· Price

 

 

Average price(s)

 

Total volume(s)

2,191.7014p

8,758

e.

Date of the transaction

2018-03-05

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUVOWRWSAORAR
Date   Source Headline
3rd Feb 202010:51 amRNSBlock listing Interim Review
23rd Jan 20203:52 pmRNSNotification of Major Holdings
2nd Jan 202010:02 amRNSTotal Voting Rights
12th Dec 20192:17 pmRNSNOTIFICATION OF MAJOR HOLDINGS
2nd Dec 20194:45 pmRNSTotal Voting Rights
20th Nov 20197:00 amRNSAppointment of Chief Financial Officer
15th Nov 20196:18 pmRNSDirector/PDMR Shareholding
14th Nov 20191:23 pmRNSResult of AGM
14th Nov 20197:00 amRNSAGM TRADING UPDATE
1st Nov 201912:05 pmRNSTotal Voting Rights
14th Oct 20198:00 amRNSAnnual Report and Annual General Meeting
10th Oct 20193:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20193:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
2nd Oct 20193:38 pmRNSNotification of Major Holdings
1st Oct 20195:23 pmRNSTotal Voting Rights
20th Sep 201912:38 pmRNSDirector/PDMR Shareholding
18th Sep 20196:09 pmRNSDirector/PDMR Shareholding
17th Sep 20191:24 pmRNSDirector/PDMR Shareholding
12th Sep 20192:59 pmRNSDirector/PDMR Shareholding
11th Sep 20198:02 amRNSCORRECTION: Outcome of IntelliGen Litigation
11th Sep 20197:00 amRNSOutcome of latest IntelliGen Litigation
10th Sep 20197:00 amRNSOUTCOME IN LATEST INTELLIGEN LITIGATION
5th Sep 20197:00 amRNSPreliminary Results
22nd Aug 20197:00 amRNSAppointment of Chief Executive Officer
1st Aug 20195:49 pmRNSBlock listing Interim Review
1st Aug 20195:46 pmRNSTotal Voting Rights
30th Jul 201912:12 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jul 20195:12 pmRNSNotification of Major Holdings
3rd Jul 20197:00 amRNSNotification of Major Holdings
1st Jul 20191:45 pmRNSTotal Voting Rights
18th Jun 20193:29 pmRNSNotification of Major Holdings
3rd Jun 20195:43 pmRNSTotal Voting Rights
24th May 20196:03 pmRNSDirector/PDMR Shareholding
16th May 20199:58 amRNSStrategic porcine collaboration in China
1st Apr 20191:54 pmRNSTotal Voting Rights
25th Mar 20197:00 amRNSGenus Chief Executive Transition
4th Mar 20193:11 pmRNSDirector/PDMR Shareholding
1st Mar 20192:00 pmRNSTotal Voting Rights
28th Feb 20197:00 amRNSInterim Results
1st Feb 20192:00 pmRNSBlock listing Interim Review
2nd Jan 20192:49 pmRNSTotal Voting Rights
11th Dec 20181:37 pmRNSDirector/PDMR Shareholding
7th Dec 20187:00 amRNSResult of placing to raise approximately £68m
6th Dec 20184:41 pmRNSProposed placing to raise approximately £68m
21st Nov 201812:00 pmRNSDirector Declaration
15th Nov 20184:00 pmRNSResult of AGM
15th Nov 20187:00 amRNSAGM Trading Update
1st Nov 20182:00 pmRNSTotal Voting Rights
12th Oct 20184:53 pmRNSAnnual Report and Annual General Meeting
12th Oct 20184:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.